FOLLOWUS
Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges
- Chinese Journal of Integrative Medicine Vol. 24, Issue 3, Pages: 163-170(2018)
- Affiliations：
1. Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine,Beijing,China
2. Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University,Lanzhou,China
3. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province,Lanzhou,China
4. Chinese GRADE Center,Lanzhou,China
5. China School of Chinese Medicine, Hong Kong Baptist University,Hong Kong SAR,China
6. Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China
7. Department of Gastroenterology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University,Beijing,China
8. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao,China
9. Department of Acupuncture and Moxibustion, Wuxi People’s Hospital,Jiangsu,China
10. Chinese Cochrane Centre, West China Hospital, Sichuan University,Chengdu,China
11. Division of Plastic Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei,China
12. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences,Beijing,China
13. Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital,Beijing,China
- Author bio：
- Funds：Supported by the National Natural Science Foundation of China (No. 81430098, 81273935, 81503459)
DOI：10.1007/s11655-017-2795-2
CLC：Published：2018，
Published Online：16 January 2018，
Scan for full text
Chen, Yl., Zhao, C., Zhang, L. et al. Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges., Chin. J. Integr. Med. 24, 163–170 (2018). https://doi.org/10.1007/s11655-017-2795-2
Yao-long Chen, Chen Zhao, Li Zhang, et al. Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges. [J]. Chinese Journal of Integrative Medicine 24(3):163-170(2018)
Chen, Yl., Zhao, C., Zhang, L. et al. Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges., Chin. J. Integr. Med. 24, 163–170 (2018). https://doi.org/10.1007/s11655-017-2795-2 DOI：
Yao-long Chen, Chen Zhao, Li Zhang, et al. Toward Evidence-Based Chinese Medicine: Status Quo, Opportunities and Challenges. [J]. Chinese Journal of Integrative Medicine 24(3):163-170(2018) DOI： 10.1007/s11655-017-2795-2.
摘要
How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries
various approaches have been used to identify and measure the efficacy and safety of CM. However
the high-quality evidence related to CM that produced in China is still rare. Over the recent years
evidence-based medicine (EBM) has been increasingly applied to CM
strengthening its theoretical basis. This paper reviews the past and present state of CM
analyzes the status quo
challenges and opportunities of basic research
clinical trials
systematic reviews
clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China
pointing out how EBM can help to make CM more widely used and recognized worldwide.
Abstract
How to test the treatments of Chinese medicine (CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM. For centuries
various approaches have been used to identify and measure the efficacy and safety of CM. However
the high-quality evidence related to CM that produced in China is still rare. Over the recent years
evidence-based medicine (EBM) has been increasingly applied to CM
strengthening its theoretical basis. This paper reviews the past and present state of CM
analyzes the status quo
challenges and opportunities of basic research
clinical trials
systematic reviews
clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China
pointing out how EBM can help to make CM more widely used and recognized worldwide.
关键词
evidence-based medicineChinese Medicinerandomized controlled trialsystematic reviewclinical practice guidelines
Keywords
evidence-based medicineChinese Medicinerandomized controlled trialsystematic reviewclinical practice guidelines
references
Group EBMW. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992;268:2420–2425.
Wang J. Evidence-based medicine in China. The Lancet 2010; 375:532–533.
Li YP, Li J, Sun X, Liu M, Zhang MM, Du L, et al. The origin and development of evidence-based medicine in China: The 20th anniversary of the Introduction of evidence-based medicine to China. Chin J Evid-Based Med (Chin) 2016;16:2–6.
Lu DD, Xu F. Chinese medicine and evidence-based medicine. Med Philoy (Chin) 2001;22:57–58.
Li YP, Liu M. Evidence-based medicine and modernization of traditional Chinese medicine. Chin J Infor Chin Med (Chin) 1999;6:14–16.
Zhang BL. Differentiation of symptoms and prescription of treatment and evidence-based medicine. Chin J Evid-Based Med (Chin) 2002;2:1–3.
Zhang SH, Chen ZH. Application of evidence-based medicine in Chinese medicine. Study J Tradit Chin Med (Chin) 2002;20:357–362.
Wang YY, Liu BY, Xie YM. Establishing appraisal mechanism of clinial studies in traditional Chinese medicine with proofing medicine methodology. Chin J Basic Med Tradit Chin Med (Chin) 2003;9:17–23.
Sheng MX. Prospect of clinical research and practice of Chinese medicines by method of EBM. Chin J Tradit Chin Med Pharm (Chin) 2003;18:485–486.
Ni W, Li J. Evidence-based medicine and research of traditional Chinese medicine and pharmacology. China J Tradit Chin Med Pharm (Chin) 2002;17:644–645.
Li N, Guo J, Wang P, Bai FL. Activator to the study of traditional Chinese medicine:method of evidence-based medicine. J Evid Based Med 2003;3:34–36.
Lai S, Hu JQ, Guo X. Evidence-based medicine and clinical studies of traditional Chinese medicine. J Guangzhou Univer Tradit Chin Med (Chin) 2000;17:1–8.
Fei F, Zhong NS. From the point of research on the prevention and treatment of influenza to see the road of traditional Chinese medicine. Chin Med Pharm (Chin) 2015;5:1–3.
Fei F, Liu SS, Zhang BL. Promote the internationalization of traditional Chinese medicine research by evidence-based medicine. Chin Med Pharm (Chin) 2015;5:1–3.
Chen KJ, Qian ZH, Zhang WQ, Guan WR, Hao XG, Chen XJ, et al. Curative effect analysis of 112 cases of angina pectoris of coronary heart disease with refined coronal slice by double blind method. Bull Med Res (Chin) 1982;11:24–25.
Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999;319:160–161.
Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial Infarction. Am J Cardiol 2008;101:1689–1693.
Li X, Zhang J, Huang J, Ma A, Yang J, Li W, et al. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of Qili Qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol 2013;62:1065–1072.
Shang H, Zhang J, Yao C, Liu B, Gao X, Ren M, et al. Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial. Evid Based Complement Alternat Med 2013;2013:738391.
Chen CLH, Young SHY, Gan HH, Singh R, Lao AY, Baroque AC 2nd, et al. Chinese medicine NeuroAID efficacy on stroke recovery: a double-blind, placebocontrolled, randomized study. Stroke 2013;44:2093–2100.
Lian F, Li G, Chen X, Wang X, Piao C, Wang J, et al. Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial. J Clin Endocrinol Metab 2014;99:648–655.
Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, et al. Oseltamivir compared with the Chinese traditional therapy Maxingshigan-Yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann Intern Med 2011;155:217–225.
Zhu HH, Wu DP, Jin J, Li JY, Ma J, Wang JX, et al. Oral tetraarsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol 2013;31:4215–4221.
Phase III trial of Dantonic® (T89) capsule to prevent and treat stable angina (CAESA). Available at: https://clinicaltrials.gov/ct2/show/NCT01659580?term=T89&rank=2.
Safety and efficacy of Kanglaite Gelcaps in prostate cancer. Available at: https://clinicaltrials.gov/ct2/show/NCT0148358 6?term=kanglaite&rank=4.
Safety and exploratory efficacy of Kanglaite Injection in pancreatic cancer. Available at: https://clinicaltrials.gov/ct2/show/NCT00733850?term=Kanglaite&rank=3.
Efficacy and safety study of lipid-lowering effects of XueZhiKang (XZK) in patients with hyperlipidemia. Available at: https://clinicaltrials.gov/ct2/show/NCT0132701 4?term=xuezhikang&rank=3.
Assess the antifibrotic activity of Fuzheng Huayu in chronic hepatitis C patients with hepatic fibrosis. Available at: https://clinicaltrials.gov/ct2/show/NCT00854087?term=Fuzh eng+Huayu&rank=1.
Phase II multi-center study of T89 to treat chronic stable angina (T89 phase 2). Available at: https://clinicaltrials.gov/ct2/show/NCT00797953?term=T89&rank=4.
Treatment of primary menstrual pain with Kanion Capsule. Available at: https://clinicaltrials.gov/ct2/show/NCT0052314 6?term=Kanion+Capsule&rank=1.
Hu CH. Clinical summary of the treatment of dysmenorrhea and irregular menstruation by concentrated Dangui Wan. Clin Pract 2004;22:394–398.
MEB annual report 2012. Available at: http://english.cbg-meb. nl/documents/annual-reports/2013/01/01/annual-report-2012.
Lei X, Chen J, Liu CX, Lin J, Lou J, et al. Status and thoughts of Chinese patent medicines seeking approval in the US market. Chin J Integr Med 2014;20:403–408.
Wang C, Liu Q. A turning point for clinical research in China? Lancet 2013;382:835–836.
Moher SDD. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid-Based Med (Chin) 2007;7:625–630.
STRICTA. Available at: http://www.stricta.info.
Cheng CW, Fu SF, Wu TX, Shang HC, Tang XD, et al. Extending the CONSORT statement to moxibustion. J Integr Med 2013:54–63.
Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials 2008;10:1–8.
Mao B, Wang G, Fan G, Chen T, Liu XD, Wang J, et al. Assessing the quality of reporting of randomized controlled trials in traditional Chinese medicine. Chin J Evid-Based Med (Chin) 2007;7:880–887.
Liu JP. Current state and countermeasures on quality of randomized controlled studies of traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2003;23:62–64.
LI TQ, Wang G, Wang L, Bao B. Clinical trials of traditional Chinese medicine in China: status and evaluation. Chin J Evid Based Med (Chin) 2005;5:431–437.
He J, Liang D, Liu G, Fu J, He X, Yu J, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials 2011;12:286–298.
Liu JP. Clinical research methodology for evidence-based Chinese medicine. Beijing: People’s Medical Publishing House;2006:93–102.
Evans D. Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs 2003;12:77–84.
Ueng TH, Kang JJ, Wang HW, Lin PC. An overview of the toxicology of commonly used traditional Chinese medicine. J Food Drug Anal 1997;5:241–263.
Chen Z, Li C, Liu S. Meta analysis on primary non-small cell lung carcinoma (NSCL) treated by TCM in China. J Tradit Chin Med (Chin) 1999;40:287–289.
Ernst E. Panax ginseng: An overview of the clinical evidence. J Ginseng Res 2010;34:259–263.
Wei W, Zhu ZZ, Jiang D, Han R. A systematic review of the berberine in protecting kidneys of diabetic rats. China J Tradit Chin Med Pharm (Chin) 2013;1622–1626.
Wang JY, Tian GH, Zhang L, Mou W, Du L, Chen YL, et al. Systematic reviews of traditional Chinese medicine/current investigation of meta-analysis. J Lanzhou Univ (Med Sci, Chin) 2016;42:48–54.
Liu JP, Mcintosh H, Lin H. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database Syst Rev 2001;7:CD001940.
Manheimer E, Windt Dvd, Udoff L, Haramati A, Langenberg P, Berman BM, et al. Effects of adjuvant acupuncture on pregnancy rates among women undergoing in vitro fertilization: systematic review and meta-analysis. BMJ 2008;336:545–549.
Fan WX, Zhong S, Liu F, Ye XF, Tu X, Huang SM. Astragalus combined with renin-angiotensin system (RAS)-inhibiting therapy for albuminuria in diabetic patients: a systematic review and meta-analysis of randomized trials. PROSPERO 2011: CRD42011001508. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp? ID=CRD42011001508.
Chung VC, Wu X, Lu P, Hui EP, Zhang Y, Zhang AL, et al. Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis. PROSPERO 2015:CRD42015023931. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015023931.
Lau CH, Wu X, Chung VC, Liu X, Hui EP, Cramer H, et al. Acupuncture and related therapy for symptom management in palliative cancer care: systematic review and metaanalysis. Medicine (Baltimore) 2016;95:e2901.
Qin ZS. Acupuncture for sciatica: a systematic review. PROSPERO 2014 CRD42014015001 Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42014015001.
Li X, Han M, Wang Y, Liu J. Chinese herbal medicine for gout: a systematic review and meta-analysis of randomized clinical trials. Clin Rheumatol 2013;32:943–959.
Luo J, Song W, Yang G, Xu H, Chen K. Compound Danshen (Salvia miltiorrhiza) Dripping Pill for coronary heart disease: an overview of systematic reviews. Am J Chin Med 2015;43:1–19.
Shneerson C, Taskila T, Gale N, Greenfield S, Chen YF. The effect of complementary and alternative medicine on the quality of life of cancer survivors: a systematic review and meta-analyses. Complement Ther Med 2013;21:417–429.
Chung VC, Wu XY, Hui EP, Ziea ET, Ng BF, Ho RS, et al. Effectiveness and safety of adjuvant Chinese herbal medicine for cancer palliative care: overview of metaanalyses. PROSPERO 2015 CRD42015016171. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42015016171.
Wu X, Chung VC, Hui EP, Ziea ET, Ng BF, Ho RS, et al. Effectiveness of acupuncture and related therapies for cancer palliative care: overview of systematic reviews. Sci Rep 2015;5:16776.
Cheong KB, Zhang JP, Huang Y. The effectiveness of acupuncture in postoperative gastroparesis syndrome and postoperative ileus: a systematic review and metaanalysis. PROSPERO 2013 CRD42013005485. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record. php?ID=CRD42013005485.
Yang G, Wang Y, Xia Y, Tian J, Liu J. Huperzine A preparation for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PROSPERO 2012 CRD42012003249. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42012003249.
Ni X, Liu S, Lu F, Guo X, Shi X. Tai chi for Parkinson’s disease: a systematic review and meta-analysis. PROSPERO 2013 CRD42013004989. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42013004989.
Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107–113.
Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000;143:923–929.
Ernst E. Adverse effects of unconventional therapies in the elderly: A systematic review of the recent literature. J Am Aging Assoc 2002;25:11–20.
Ernst E, Thompson CJ. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001;70:497–504.
Fugh-Berman A, Ernst E. Herb–drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587–595.
Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003;162:72–80.
LI TQ, Liu XM, Zhang MM, Du L, Zhou YD, Chang J, et al. Assessment of systematic reviews and meta-analyses on traditional Chinese medicine published in Chinese journals. Chin J Evid-Based Med (Chin) 2007;7:180–188.
Chang YP. The quality of meta analysis and research related to medicine. J Prac Tradit Chin Inter Med (Chin) 2014;28:8–9.
Wei ML, Liu M, Wei S. The current status on systematic reviews/meta-analysis in Chinese publications from 1990-2007. West China Med J (Chin) 2007;22:697–698.
Dan HU, Kang DY, Wu YX. Methodological quality assessment of systematic reviews correlated to traditional Chinese medicine published in China. Chin J Integr Tradit West Med (Chin) 2011;31:402–406.
Liu JP, Xia Y. Quality appraisal of systematic reviews or metaanalysis on traditional Chinese medicine published in Chinese journals. Chin J Integr Tradit West Med (Chin) 2007;27:306–311.
Spence D. Evidence based medicine is broken. BMJ 2014;348:G22.
Institute of Medicine. Clinical practice guidelines we can trust. Washington: The National Academies Press, 2011.
China Academy of Chinese Medical Sciences, China Association for Acupuncture and Moxibustion. Evidence-based guidelines of clinical practice in Chinese medicine: acupuncture. Beijing: China Press of Traditional Chinese Medicine, 2011:19–142.
China Academy of Chinese Medical Sciences. Evidencebased guidelines of clinical practice in Chinese medicine: Internal Medicine. Beijing: China Press of Traditional Chinese Medicine 2011:1–434.
China Academy of Chinese Medical Sciences. Evidencebased guidelines of clinical practice in Chinese medicine: specific disease. Beijing: China Press of Traditional Chinese Medicine;2011:1-148.
Ya Y, Han X, Zhang H, Wang LY, Shi NN, Wang YY, et al. Study on quality assessment of TCM clinical practice guidelines based on AGREE instrument. World Sci Tech Modern Tradit Chin Med Mater Med (Chin) 2011;13:596–600.
Shi NN, Han XJ, Ya Y, Liu YQ, Wang YX, Wang LY, et al. Method of applicable adaptation of clinical practice guidelines and its inspiration on Chinese medicine clinical practice guidelines. Chin J Tradit Chin Med Pharm (Chin) 2014;10:3166–3169.
Wang LY, Zhao XY, Yu WY, Liu YQ, Wang YX, Liu MY, et al. Comparison of clinical practice guidelines with clinical pathways and diagnosis & treatment schemes in Chinese medicine. J Tradit Chin Med (Chin) 2015;56:2112–2115.
Zhao WT. Construction of "healthy China", fast pace of Chinese medicine. Available from: http://www.saCM.gov.cn/e/action/ShowInfo.php?classid=56&id=22057. html.
Chen YL, Yang KH, Yao L, Tian JH, Bai ZG, Ma B. The development of GRADE systematic methodology. Chin J Evid-Based Med (Chin) 2013;8:1–2.
Planning and Finance Department of the State Administration of Traditional Chinese Medicine. The number of higher traditional Chinese medicine colleges, the number of higher institutions of Western medicine. Non-medical college in China In 2014. http://www.saCM.gov.cn/1999-2011/Abstracts of Chinese Medicine Statistics /atog/2014/C01.html.
Developing and Planning Department of the Ministry of Education of the People’s Republic of China. Colleges and Universities set. http://old.moe.gov.cn/publicfiles/business/htmlfiles/moe/s181/index.html.
The Ministry of Education of the People’s Republic of China (MOE). 2015 National Statistic for Institutions of Higher Education. http://old.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_229/201505/187754. html.
Jin C, Liu GJ, LI J, Li W. A survey of evidence-based medicine teaching in China. Chin J Evid-Based Med (Chin) 2005;5:955–957.
Geng JS, Dong JC, Ni HJ. Impact of evidence-based medicine curriculum on medical students in China: a systematic review approach. China Higher Med Ed (Chin) 2012;3:43–45.
MA L, Jiang JG, Yu SX. Analysis of the perception level of clinicians on EBM. Modern Prev Med (Chin) 2008;35:2617–2619.
Dong BR, Ding QF. Investigating the awareness and application of EBM in the clinical practice. West China Med J (Chin) 2000;15:125–127.
Liu B. A primary survey of evidence-based medicine and traditional Chinese medicine. Chin J Evid-Based Med (Chin) 2004;19:44–49.
Shang HC, Zhang BL. Country-led, multi-stakeholder involvement, and jointly promote the overall level of CM clinical research. Chin Evid-Based Med (Chin) 2010;10:640–641.
Shang HC, Zhang BL, Wang YY. Clinical research of traditional Chinese medicine needs "a breakthrough". Tianjin J Tradit Chin Med (Chin) 2013;30:4–5.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 2010;63:1308–1311.
Schünemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ 2014;186:123–142.
Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: The RIGHT statement. Ann Intern Med 2017;166:128–132.
0
Views
0
Downloads
4
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
